Tuesday, 30 January 2018

Brexit could leave patients unable to access new drugs

Brexit could leave patients unable to access new drugs
NHS may only get newly developed medicines a year after other EU countries, report warns
Patients could face long delays obtaining new drugs or be denied access to them altogether as a result of Brexit, a coalition of doctors, NHS bosses and pharmaceutical firms warns. The Guardian.

See also:

No comments:

Post a Comment